Display Accessibility Tools

Accessibility Tools


Highlight Links

Change Contrast

Increase Text Size

Increase Letter Spacing

Readability Bar

Dyslexia Friendly Font

Increase Cursor Size

Mengyu Liu

Mengyu completed her PhD research under the guidance of Dr. Min-Hao Kuo. Her research focuses on small-molecule modulators of the aggregation of hyperphosphorylated tau (p-tau) include potential risk factors and therapeutics for Alzheimer’s disease. Using a combination of in vitro aggregation assay and cell-based cytotoxicity assay, Mengyu has found two prescription drugs as potent p-tau aggregation inhibitors that also attenuate p-tau cytotoxicity. Conversely, selective benzodiazepines were found to enhance p-tau aggregation and cytotoxicity. Mengyu is now working as post-doc with Dr. Kuo on high-throughput screening of p-tau aggregation modulators.